For adults treating their Stage 3 or 4 classical Hodgkin lymphoma for the first time
ADCETRIS + AVD MAY
Amina was treated with ADCETRIS plus AVD*
Classical Hodgkin lymphoma, also called Hodgkin’s lymphoma, Hodgkin’s disease, or Hodgkin’s, is a type of cancer of the blood. It starts when lymphocytes, a type of white blood cell, grow out of control.
People with classical Hodgkin lymphoma have abnormal white blood cells called Reed-Sternberg cells in their lymph nodes. These cells usually have a specific protein on their surface called CD30, which is a key marker of Hodgkin’s. In fact, CD30 is present in approximately 95% of all cases of Hodgkin lymphoma.
Click here to learn more about how ADCETRIS is designed to attach to CD30 to help fight Hodgkin lymphoma.
Relapsed classical Hodgkin lymphoma
For those who have classical Hodgkin lymphoma that has come back after 2 or more treatments, see how ADCETRIS may have helped.
After stem cell replacement
For those who have classical Hodgkin lymphoma at high risk of coming back or getting worse after a stem cell transplant, see how ADCETRIS may have helped.
Why ADCETRIS is different
Learn how effective ADCETRIS was in clinical studies and how it works.
How ADCETRIS is given
Learn more about what you can expect before starting ADCETRIS treatment.
Resources
Find resources, financial assistance information, and ways to connect with others.